SG Americas Securities’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.7M | Buy |
1,149,081
+986,567
| +607% | +$13.5M | 0.07% | 208 |
|
|
2025
Q1 | $1.8M | Buy |
162,514
+142,245
| +702% | +$1.57M | 0.01% | 758 |
|
|
2024
Q4 | $216K | Buy |
20,269
+6,207
| +44% | +$66.1K | ﹤0.01% | 1834 |
|
|
2024
Q3 | $179K | Buy |
+14,062
| New | +$179K | ﹤0.01% | 2301 |
|
|
2024
Q1 | – | Sell |
-8,707
| Closed | -$131K | – | 3020 |
|
|
2023
Q4 | $131K | Buy |
+8,707
| New | +$131K | ﹤0.01% | 2314 |
|
|
2021
Q4 | – | Sell |
-10,318
| Closed | -$174K | – | 3367 |
|
|
2021
Q3 | $174K | Buy |
+10,318
| New | +$174K | ﹤0.01% | 3054 |
|
|
2021
Q2 | – | Sell |
-5,235
| Closed | -$102K | – | 2868 |
|
|
2021
Q1 | $102K | Sell |
5,235
-51,009
| -91% | -$994K | ﹤0.01% | 2803 |
|
|
2020
Q4 | $1.01M | Sell |
56,244
-5,492
| -9% | -$99K | 0.01% | 1345 |
|
|
2020
Q3 | $1.19M | Sell |
61,736
-69,914
| -53% | -$1.35M | 0.01% | 887 |
|
|
2020
Q2 | $3.44M | Buy |
131,650
+30,053
| +30% | +$785K | 0.03% | 406 |
|
|
2020
Q1 | $1.81M | Buy |
101,597
+51,257
| +102% | +$914K | 0.02% | 662 |
|
|
2019
Q4 | $1.68M | Buy |
50,340
+585
| +1% | +$19.5K | 0.02% | 823 |
|
|
2019
Q3 | $1.19M | Buy |
+49,755
| New | +$1.19M | 0.01% | 1144 |
|